Wave Life Sciences Profit Margin

Wave Life Sciences (WVE) currently reports a profit margin of -309.73% as of June 2026. That compares with -138.24% in the prior-year period — down 124.0% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Wave Life Sciences's profit margin history and peer comparisons.

Wave Life Sciences's profit margin decreased from -138.24% to -309.73% — a 124.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Wave Life Sciences's profit margin of -309.73% is lower than the Healthcare sector average of 15.29%. That is roughly 2125.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Wave Life Sciences's current -309.73% should be judged against Healthcare norms (sector average: 15.29%) and against WVE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -309.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Wave Life Sciences, and consider following WVE for alerts when major investors trade the stock.